Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-000253
Filing Date
2021-01-06
Accepted
2021-01-06 21:46:09
Documents
1
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 form4-01062021_060102.html 4  
1 form4-01062021_060102.xml 4 3941
  Complete submission text file 0001415889-21-000253.txt   5425
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1300 MORRIS PARK AVE. BIOCHEMISTRY DEPT. BRONX NY 10461
Business Address
Schramm Vern Lee (Reporting) CIK: 0001719553 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 21512874